BRAF mutation was more frequently observed in ulcerated melanomas with a high mitotic rate ≥ 5 n/mm2 (a measure of how fast melanoma cells are growing), while NRAS mutation was associated with amelanotic/hypomelanotic (subtype with little or no pigmentation) and nodular melanoma. Here, BRAF is linked to nodular malignant melanoma.